TY - JOUR
T1 - The American Heart Association's Call to Action for Reducing the Global Burden of Rheumatic Heart Disease
T2 - A Policy Statement from the American Heart Association
AU - Beaton, Andrea
AU - Kamalembo, Flavia B.
AU - Dale, James
AU - Kado, Joseph H.
AU - Karthikeyan, Ganesan
AU - Kazi, Dhruv S.
AU - Longenecker, Chris T.
AU - Mwangi, Jeremiah
AU - Okello, Emmy
AU - Ribeiro, Antonio Luiz P.
AU - Taubert, Kathryn A.
AU - Watkins, David A.
AU - Wyber, Rosemary
AU - Zimmerman, Meghan
AU - Carapetis, Jonathan
N1 - Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/10/19
Y1 - 2020/10/19
N2 - Rheumatic heart disease (RHD) affects ≈40 million people and claims nearly 300 000 lives each year. The historic passing of a World Health Assembly resolution on RHD in 2018 now mandates a coordinated global response. The American Heart Association is committed to serving as a global champion and leader in RHD care and prevention. Here, we pledge support in 5 key areas: (1) professional healthcare worker education and training, (2) technical support for the implementation of evidence-based strategies for rheumatic fever/RHD prevention, (3) access to essential medications and technologies, (4) research, and (5) advocacy to increase global awareness, resources, and capacity for RHD control. In bolstering the efforts of the American Heart Association to combat RHD, we hope to inspire others to collaborate, communicate, and contribute.
AB - Rheumatic heart disease (RHD) affects ≈40 million people and claims nearly 300 000 lives each year. The historic passing of a World Health Assembly resolution on RHD in 2018 now mandates a coordinated global response. The American Heart Association is committed to serving as a global champion and leader in RHD care and prevention. Here, we pledge support in 5 key areas: (1) professional healthcare worker education and training, (2) technical support for the implementation of evidence-based strategies for rheumatic fever/RHD prevention, (3) access to essential medications and technologies, (4) research, and (5) advocacy to increase global awareness, resources, and capacity for RHD control. In bolstering the efforts of the American Heart Association to combat RHD, we hope to inspire others to collaborate, communicate, and contribute.
UR - http://www.scopus.com/inward/record.url?scp=85096347429&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000000922
DO - 10.1161/CIR.0000000000000922
M3 - Review article
C2 - 33070654
AN - SCOPUS:85096347429
SN - 0009-7322
VL - 142
SP - E358-E368
JO - Circulation
JF - Circulation
IS - 20
ER -